Home / News / India News / Article / Govt caps trade margins on non-scheduled cancer drugs at 30 pc of MRP; patients may save Rs 2,500 cr

Govt caps trade margins on non-scheduled cancer drugs at 30 pc of MRP; patients may save Rs 2,500 cr

Under the new measure, margins charged on the supply and sale of non-scheduled anti-cancer drugs will be limited to 30 per cent of their maximum retail price (MRP). These medicines fall outside the list of drugs covered by government-fixed ceiling prices

  • WhatsAppBookmarkBookmark
Listen to this article :
Representational Image

Representational Image

The government has approved a cap on trade margins for non-scheduled anti-cancer medicines, aiming to curb excessive mark-ups and reduce treatment costs for patients. The move is expected to lower prices of affected medicines by up to 70 per cent and generate annual savings of around Rs 2,500 crore, according to the Department of Pharmaceuticals.

Trade margins capped at 30 per cent of MRP

Under the new measure, margins charged on the supply and sale of non-scheduled anti-cancer drugs will be limited to 30 per cent of their maximum retail price (MRP). These medicines fall outside the list of drugs covered by government-fixed ceiling prices.

Read Next Story
Delhi Police register FIR over assault on Kashmiri youth during INDIA bloc protest›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All